Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients
Metadatos
Mostrar el registro completo del ítemEditorial
Plos
Fecha
2022-07-14Referencia bibliográfica
Trujillo-Rodriguez M, Muñoz-Muela E, Serna-Gallego A, Praena-Ferna´ndez JM, Pe´rez- Go´mez A, Gasca-Capote C, et al. (2022) Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients. PLoS ONE 17(7): e0269875. [https://doi.org/10.1371/journal.pone.0269875]
Patrocinador
Consejeria de Salud y Familia COVID-00052020 RH-0037-2020; Consejeria de Transformacion Economica, Industria, Conocimiento y Universidades PY20/01276; Instituto de Salud Carlos III CP19/00159 CP19/00146 FI19/00304 FI19/00083 COV20/00698; Red Tematica de Investigacion Cooperativa en SIDA RD16/0025/0020 RD16/0025/0006 RD16/0025/0026; European Commission; Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas-ISCIII Madrid, Spain CB21/13/00020; Spanish Research Council (CSIC); IISPV 2019/IISPV/05; GeSIDAResumen
Background
The SARS-CoV-2 pandemic has overwhelmed hospital services due to the rapid transmission
of the virus and its severity in a high percentage of cases. Having tools to predict which
patients can be safely early discharged would help to improve this situation.
Methods
Patients confirmed as SARS-CoV-2 infection from four Spanish hospitals. Clinical, demographic,
laboratory data and plasma samples were collected at admission. The patients
were classified into mild and severe/critical groups according to 4-point ordinal categories
based on oxygen therapy requirements. Logistic regression models were performed in mild
patients with only clinical and routine laboratory parameters and adding plasma pro-inflammatory
cytokine levels to predict both early discharge and worsening.
Results
333 patients were included. At admission, 307 patients were classified as mild patients.
Age, oxygen saturation, Lactate Dehydrogenase, D-dimers, neutrophil-lymphocyte ratio
(NLR), and oral corticosteroids treatment were predictors of early discharge (area under curve (AUC), 0.786; sensitivity (SE) 68.5%; specificity (S), 74.5%; positive predictive value
(PPV), 74.4%; and negative predictive value (NPV), 68.9%). When cytokines were included,
lower interferon-γ-inducible protein 10 and higher Interleukin 1 beta levels were associated
with early discharge (AUC, 0.819; SE, 91.7%; S, 56.6%; PPV, 69.3%; and NPV, 86.5%).
The model to predict worsening included male sex, oxygen saturation, no corticosteroids
treatment, C-reactive protein and Nod-like receptor as independent factors (AUC, 0.903;
SE, 97.1%; S, 68.8%; PPV, 30.4%; and NPV, 99.4%). The model was slightly improved by
including the determinations of interleukine-8, Macrophage inflammatory protein-1 beta and
soluble IL-2Rα (CD25) (AUC, 0.952; SE, 97.1%; S, 98.1%; PPV, 82.7%; and NPV, 99.6%).
Conclusions
Clinical and routine laboratory data at admission strongly predict non-worsening during the
first two weeks; therefore, these variables could help identify those patients who do not
need a long hospitalization and improve hospital overcrowding. Determination of pro-inflammatory
cytokines moderately improves these predictive capacities.





